Leveraging EUnetHTA’s conceptual framework to compare HTA decision drivers in France, Italy, and Germany from a manufacturer’s point of view

BACKGROUND: Health Technology Assessments (HTA) procedures differ substantially across the various European countries. We reviewed recent appraisals of a pharmaceutical manufacturer in three major European markets (France; Italy; Germany) and identified and categorized related decision drivers. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Giuliani, Giovanni, Chassagnol, Frederic, Traub, David, Gyldmark, Marlene, Hebborn, Ansgar, Ducournau, Pierre, Ruof, Jörg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755607/
https://www.ncbi.nlm.nih.gov/pubmed/30242522
http://dx.doi.org/10.1186/s13561-018-0201-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755607/
https://www.ncbi.nlm.nih.gov/pubmed/30242522
http://dx.doi.org/10.1186/s13561-018-0201-y

Ejemplares similares